Investor Presentaiton
Strong Existing Clinical Data Set Underpins Surgeon Adoption ne
Recent Peer Review Data
Publication
Consistency in Standalone Canaloplasty
Outcomes Using the iTrack Microcatheter
Authors
Journal
Khaimi, M (USA,
Gallardo M (USA)
and Korber N
(Germany).
Clinical
Ophthalmology,
2024.
Clinical outcomes of canaloplasty via an ab-
interno surgical technique using the iTrack
device: a narrative review
6-Year Efficacy and Safety of iTrack Ab-
interno Canaloplasty as a Standalone
Procedure and Combined
with Cataract Surgery in Primary Open-
Angle and Pseudoexfoliative Glaucoma
Long-Term Clinical and Safety Outcomes of
Canaloplasty Performed across All Grades
of Glaucoma Severity
Surgical Management of Intraocular
Pressure With Ab-interno Canaloplasty in
Postkeratoplasty Patients:
12-Month Results
Koerber N
(Germany), Ondrejka
S (Germany).
Koerber N
(Germany), Ondrejka
S (Germany).
International
Ophthalmology,
.
2023.
Journal of
Ophthalmology,
2023.
Journal of
Ophthalmology,
Patel S (USA),
Reiss G (USA).
2023.
.
•
•
•
Riaz KM et al (USA).
Cornea, 2023.
•
Data Overview
Multicenter, multi-surgeon, retrospective review of a consecutive case series
At 12 months, IOP (mmHg) was reduced in 57 of the 58 (98%) remaining eyes; one eye
had the same IOP with a reduced number of medications.
Nine studies which totalled 365 eyes.
At 12 and 24 months, IOP (mmHg) decreased from 20.0±2.5 preoperatively to 13.8±0.6
and 14.0±0.9.
Single-center retrospective case series of patients (n=27 eyes) followed for up to 6
years.
The mean IOP was reduced significantly from 19.9±5.2 mmHg (n=27) at baseline (no
washout) to 14.6±3.3 mmHg at the 6-year follow-up (n=18; p<0.001).
Single-center, retrospective case series study of glaucoma eyes (n=72) with mild-
moderate glaucoma as compared to severe glaucoma.
The mean preoperative IOP for the 72 eyes was 18.6±5.8 mmHg, which showed a 25%
reduction to 13.5±4.7 mmHg at 36 months (p<0.001).
Single-center, retrospective case series of postkeratoplasty eyes(n=17) undergoing ab-
interno canaloplasty (ABIC).
ABIC effectively reduced IOP and maintained graft survivability in postkeratoplasty
eyes for at least 12 months.
nova-eye.com | 19View entire presentation